UK Markets close in 2 hrs 1 min

Novo Nordisk A/S (NVO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
81.65-0.51 (-0.62%)
At close: 4:00PM EDT
82.18 +0.53 (0.65%)
Pre-market: 09:26AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close82.16
Open82.57
Bid0.00 x 1300
Ask0.00 x 800
Day's range81.65 - 82.57
52-week range63.22 - 84.94
Volume583,781
Avg. volume905,629
Market cap188.384B
Beta (5Y monthly)0.30
PE ratio (TTM)27.96
EPS (TTM)2.92
Earnings dateN/A
Forward dividend & yield1.84 (2.49%)
Ex-dividend date26 Mar 2021
1y target est82.50
  • Globe Newswire

    Novo Nordisk A/S – Share repurchase programme

    Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 21 June 2021 – On 7 May 2021, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 18 billion to be executed during a 12-month period beginnin

  • Here's Why Altimmune Stock Is Surging Today
    Motley Fool

    Here's Why Altimmune Stock Is Surging Today

    Shares of Altimmune (NASDAQ: ALT), a clinical-stage biopharmaceutical company, are on the move following a positive clinical readout. Investors excited about the company's potential new weight loss drug drove the stock 23% higher as of 12:34 p.m. on Wednesday. Altimmune's weight loss drug candidate, ALT-801, is a GLP-1 receptor agonist that also activates glucagon receptors.

  • The Zacks Analyst Blog Highlights: Microsoft, Nike, Novo Nordisk, Caterpillar and General Electric
    Zacks

    The Zacks Analyst Blog Highlights: Microsoft, Nike, Novo Nordisk, Caterpillar and General Electric

    The Zacks Analyst Blog Highlights: Microsoft, Nike, Novo Nordisk, Caterpillar and General Electric